EW - CIK 0001099800
Edwards Lifesciences Corp trades as EW and has a market capitalization of $49.51 B, making it the #320 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $6.07B, up 11.5% from the prior year and net income of $1.07B. This page tracks Edwards Lifesciences Corp through 2,569 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Edwards Lifesciences Corp's revenue grew from $2.96B to $6.07B, a compound annual growth rate of 8.3%. Net profit margin compressed from 28.7% to 17.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
The largest companies sharing Edwards Lifesciences Corp's SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
Edwards Lifesciences Corp (EW) has a market capitalization of $49.51 B as of 2026-06-10, ranking #320 among US-listed companies.
Edwards Lifesciences Corp reported revenue of $6.07B for fiscal year 2025, an increase of 11.5% year over year.
Yes. Edwards Lifesciences Corp reported net income of $1.07B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.